COVID-19 mild to moderate | |
COVID-19 mild to moderate | |
non-steroidal anti-inflammatory drugs | Guzman-Esquivel |
Indomethacin | Ravichandran |
5423 | Jeong, 2020 | 1 | 15 | 0 | not a RCT | risk of bias not avaialble | |
5764 | Wenxin, 2020 | 1 | 10 | 0 | not a RCT | risk of bias not avaialble | |
6188 | Bruce, 2020 | 1 | 10 | 0 | not a RCT | risk of bias not avaialble | |
6361 | Ravichandran, 2020 | 1 | 10 | 0 | not a RCT | risk of bias not avaialble | |
6960 | Imam, 2020 | 1 | 13 | 0 | not a RCT | risk of bias not avaialble | |
7011 | Drake, 2021 | 1 | 10 | 0 | not a RCT | risk of bias not avaialble |